EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA

Caitlin M Turner iD, Joy M Schmitz, Janet Ikeda, Glenn-Milo Santos

Addiction · 2025

DOI: 10.1111/add.70054 ↗

At a glance

Randomisierte kontrollierte Studie in Addiction, 2025. Written by Caitlin M Turner and 3 co-authors. Institution: Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Major MEDLINE topics: Naltrexone, Sexual and Gender Minorities, Alcoholism, Narcotic Antagonists. 47 references. Funded by: NIH HHS, NIAAA NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

To determine whether there were within‐week associations between changes in alcohol use and changes in cannabis, cocaine or amphetamines use and, if so, to ascertain whether these associations varied by naltrexone use among adult sexual and gender minority men (SGMM) with mild and moderate alcohol use disorder (AUD).

Design

Secondary analyses of data from the Say When study, a double‐blind placebo‐controlled trial comparing targeted oral naltrexone (50 mg) to placebo for AUD over 12 weeks.

Setting

Procedures were conducted at the San Francisco Department of Public Health from May 2015 to November 2020, in San Francisco, California, USA.

Participants

98 of 120 SGMM who reported substance use beyond alcohol.

Measurements

Mixed effects logistic regression models tested associations between alcohol exposures [ethyl‐glucuronide (EtG)‐positive urine screens, past‐week binge drinking and past‐week binge drinking frequency] and same‐week use of other substances (positive urine screens for cannabis, cocaine or amphetamines), adjusting for age, race/ethnicity, income, depression score and treatment assignment. Associations by treatment assignment (naltrexone or placebo) were also evaluated.

Findings

Having a positive EtG urine screen was associated with higher odds of positive urine screens for cannabis [adjusted odds ratio (aOR) = 2.93, 95% confidence interval (95% CI) = 1.37–6.30, P = 0.006) or cocaine (aOR = 3.08, 95% CI = 1.52–6.23, P = 0.002). Each additional binge drinking day was associated with higher odds of having a positive urine screen for cocaine (aOR = 1.29, 95% CI = 1.04–1.60, P = 0.018). Among those receiving naltrexone, greater binge drinking days was associated with increased odds of having a positive urine screen for cocaine (aOR = 1.64, 95% CI = 1.18–2.27, P = 0.003), while results for cannabis and amphetamines were not statistically significant.

Conclusions

Among adult sexual and gender minority men enrolled in a clinical trial, alcohol use was positively associated with cannabis and cocaine use. Naltrexone may mitigate cocaine use in this group by moderating binge drinking or diminishing the rewarding effects of cocaethylene. Findings highlight the potential of targeted naltrexone as an intervention to address alcohol and cocaine co‐use and improve treatment outcomes in this underserved group.

Subjects

MeSH terms (MEDLINE)

NaltrexoneSexual and Gender MinoritiesAlcoholismNarcotic AntagonistsSubstance-Related DisordersAlcohol DrinkingHumansMaleAdultSan FranciscoDouble-Blind MethodMiddle AgedBinge DrinkingYoung AdultGlucuronatesCocaine-Related Disorders

Author keywords

AUDalcoholcocaineinteractionmixed effects modelsmultisubstancenaltrexonesexual and gender minority men

Substances

NaltrexoneNarcotic AntagonistsGlucuronatesethyl glucuronide

Authors and institutions

  • Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
  • Center for Neurobehavioral Research on Addiction, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas at Houston, Houston, TX, USA.
  • Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Department of Community Health Systems, University of California, San Francisco, CA, USA.

ORCID profiles: Caitlin M Turner

Funding

  • NIH HHS
  • NIAAA NIH HHS
  • National Institutes of Health

Cite

APA

Turner, C. M., Schmitz, J. M., Ikeda, J., & Santos, G. M. (2025). Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA. Addiction. https://doi.org/10.1111/add.70054

Vancouver

Turner CM, Schmitz JM, Ikeda J, Santos GM. Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA. Addiction. 2025. doi:10.1111/add.70054

BibTeX
@article{Turner2025,
  author = {Turner, Caitlin M and Schmitz, Joy M and Ikeda, Janet and Santos, Glenn-Milo},
  title = {Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.70054}
}
Start for free →